Personal details of:

Prof. Dr. dr. Erni Juwita Nelwan, PhD, SpPD, K-PTI, FACP, FINASIM
Formal Academic
• B. Sc (1999) Universitas Indonesia , Indonesia
• MD (2001) Universitas Indonesia, Indonesia
• Sp.PD (2007) Universitas Indonesia, Indonesia
• K-PTI (2013) Universitas Indonesia, Indonesia
• Ph.D (2017) Radboud University Nijmegen Medical Centre, Netherland
• Doctor (2021) Universitas Indonesia, Indonesia

Affiliations
• 2020 – present: Head Division of Tropical and Infectious Diseases. Department of Internal Medicine,
Cipto Mangunkusumo Hospital
• 2017 – present: Senior Researcher Indonesian Medical Education & Research Institute (IMERI) FKUI
• 2009 – present: Teaching Staff Faculty of Medicine, Universitas Indonesia

• Organizations:
1.Indonesian Physicians Association (IDI)
2.Indonesian Society of Internal Medicine (PAPDI)
3.Indonesian Association of Tropical Medicine and Infectious Diseases (PETRI)
4.Infectious Diseases Society of America (IDSA)
5.Fellow of the American College of Physicians (FACP)
Gambaran Umum
Penyakit Virus Nipah
Dipresentasikan pada Sosialiasi Tools Pemetaan Risiko Penyakit Virus Nipah
Senin, 20 November 2023
Online

Prof. Dr. dr. Erni Juwita Nelwan, PhD, SpPD, K-PTI, FACP, FINASIM
Division of Tropical and Infectious Diseases, Department of Internal Medicine
Cipto Mangunkusumo National Center Hospital, Faculty of Medicine Universitas Indonesia
 INTRODUCTION
Nipah virus (NiV) infection
is a zoonotic virus and can also be transmitted through
contaminated food or directly between people

The first human cases were observed in Malaysia in

1998–1999, near Nipah River village

Fruit bats (Pteropodidae family)

are the natural host of NiV

The case fatality rate (CFR) is estimated at 40% to 75%

CFR can vary by outbreak depending on local capabilities for
epidemiological surveillance and clinical management.
https://www.who.int/news-room/fact-sheets/detail/nipah-virus (Last updated: 30 May 2018)
Garbuglia AR, et al. Viruses 2023, 15, 2062
 MAP OF NiV OUTBREAKS AND
PTEROPUS FRUIT BATS DISTRIBUTION

Pillai VS, et al. Viruses 2020;12(4)

 Hingga saat ini keberadaan virus nipah pada manusia di Indonesia belum banyak
diketahui. Namun mengingat letak geografis Indonesia berdekatan dengan negara
yang melaporkan wabah, maka kemungkinan risiko penyebaran dapat terjadi.

https://setkab.go.id/kemenkes-terbitkan-edaran-kewaspadaan-terhadap-virus-nipah/
WHO South-East Asia Regional Strategy for the prevention and control of Nipah virus infection, 2023–2030
 NIPAH VIRUS (NiV) TRANSMISSION ROUTE

Gazal S, et al. Pathogens. 2022;11(12):1419

 PATHOGENESIS OF NiV

Singh RK, et al. Veterinary Quarterly 2019;39(1):26–55

Hassan D, et al. J Pure Appl Microbiol. 2022;16(1):26-34
 DEFINISI OPERASIONAL KASUS
SUSPEK

KEMENKES. Pedoman Pencegahan dan Pengendalian Penyakit Virus Nipah. 2021

 DEFINISI OPERASIONAL KASUS
PROBABLE

KONFIRMASI

KEMENKES. Pedoman Pencegahan dan Pengendalian Penyakit Virus Nipah. 2021

 DEFINISI OPERASIONAL KASUS
KONTAK ERAT

KEMENKES. Pedoman Pencegahan dan Pengendalian Penyakit Virus Nipah. 2021

 PEMERIKSAAN LABORATORIUM

KEMENKES. Pedoman Pencegahan dan Pengendalian Penyakit Virus Nipah. 2021

 PEMERIKSAAN LABORATORIUM

KEMENKES. Pedoman Pencegahan dan Pengendalian Penyakit Virus Nipah. 2021

 TREATMENT

There are currently no drugs or vaccines specific for Nipah

virus infection although WHO has identified Nipah as a priority
disease for the WHO Research and Development Blueprint.

Intensive supportive care is recommended to treat severe

respiratory and neurologic complications.

Treatment is limited to supportive care, including

rest, hydration, and treatment of symptoms as they
occur.

https://www.who.int/news-room/fact-sheets/detail/nipah-virus
https://www.cdc.gov/vhf/nipah/treatment/index.html
 CONCLUSION

▰ Penemuan kasus sangat penting di lakukan

▰ Pemahaman mekanisme pencegahan penularan
▰ Komunikasi Risiko dan Pemberdayaan Masyarakat

17
--THANK YOU--

18